Assessment of chemical libraries for their druggability

Computational Biology and Chemistry

Volumn 29, Issue 1, 2005, Pages 55-67

  Sirois, Suzanne ^a,b,e   Hatzakis, George ^a   Wei, Dongqing ^c,d,e   Du, Qishi ^c,e   Chou, Kuo Chen ^c,e  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c Tianjin Inst Bioinfo Drug Discov   (China)

^d Gina Cody School of Engineering and Computer Science   (Canada)

^e GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

12 Metric scoring function; Database score; Drug score; High throughput screening (HTS); Targeted compound libraries

Indexed keywords

CHEMICAL LABORATORIES; DATABASE SYSTEMS; DRUG PRODUCTS; GENES; GENETIC ENGINEERING; METABOLISM; MOLECULAR WEIGHT;

12-METRIC SCORING FUNCTION; CHEMICAL LIBRARIES; DATABASE SCORE; DRUG SCORE; HIGH THROUGHPUT SCREENING (HTS); TARGETED COMPOUND LIBRARIES;

DIGITAL LIBRARIES;

DRUG;

ARTICLE; CHEMISTRY; CLASSIFICATION; COMPUTER AIDED DESIGN; FACTUAL DATABASE; LIBRARY;

CHEMISTRY, PHARMACEUTICAL; COMPUTER-AIDED DESIGN; DATABASES, FACTUAL; LIBRARIES; PHARMACEUTICAL PREPARATIONS;

EID: 12444322042     PISSN: 14769271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiolchem.2004.11.003     Document Type: Article

References (49)

1. A. Ajay, W.P. Walters, and M.A. Murcko Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem. 41 1998 3314 3324
2. J. Bajorath Integration of virtual and high-throughput screening Nat. Rev. Drug Discov. 1 2002 882 894
3. Baurin, N., Etude et développement de techniques QSAR pour la recherche de molécules d'intérêts thérapeutique. Criblage virtuel et Analyse de chmiothèque, Université d'Orléans, 2002.
4. P.S. Charifson, and W.P. Walters J. Comput. Aided Mol. Des. 16 2002 311 323
5. K.C. Chou Graphical rules in steady and non-steady enzyme kinetics J. Biol. Chem. 264 1989 12074 12079
6. Chou, 1990. Review: Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady state systems. Biophys. Chem. 35, 1-24.
7. K.C. Chou A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins J. Biol. Chem. 268 1993 16938 16948
8. K.C. Chou Review: prediction of HIV protease cleavage sites in proteins Anal. Biochem. 233 1996 1 14
9. K.C. Chou A new branch of proteomics: prediction of protein cellular attributes P.W. Weinrer Q. Lu Gene Cloning & Expression Technologies 2002 Eaton Publishing Westborough, MA 57 70 Chapter 4
10. K.C. Chou Insights from modelling the 3D dtructure of the extracellular domain of alpha7 nicotinic acetylcholine receptor Biochem. Biophys. Res. Commun. 319 2004 433 438
11. K.C. Chou Insights from modelling three-dimensional structures of the human potassium and sodium channels J. Prot. Res. 3 2004 856 861
12. K.C. Chou Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5 Biochem. Biophys. Res. Commun. 316 2004 636 642
13. K.C. Chou Review: structural bioinformatics and its impact to biomedical science Curr. Med. Chem. 11 2004 2105 2134
14. K.C. Chou, and Y.D. Cai Using functional domain composition and support vector machines for prediction of protein subcellular location J. Biol. Chem. 277 2002 45765 45769
15. K.C. Chou, and Y.D. Cai Prediction and classification of protein subcellular location: sequence-order effect and pseudo amino acid composition J. Cell. Biochem. 90 2003 1250 1260 Addendum, ibid, 2004, 91, no. 5, p. 1085
16. Chou, K.C., Cai, Y.D., 2004a. A novel approach to predict active sites of enzyme molecules. PROTEINS: Structure, Function, and Genetics 55, 77-82.
17. K.C. Chou, and Y.D. Cai Predicting enzyme family class in a hybridization space Protein Science 13 2004 2857 2863
18. K.C. Chou, and Y.D. Cai Using GO-PseAA predictor to predict enzyme sub-class Biochem. Biophys. Res. Comm. 325 2004 506 509
19. K.C. Chou, and D.W. Elrod Bioinformatical analysis of G-protein-coupled receptors J. Prot. Res. 1 2002 429 433
20. K.C. Chou, and D.W. Elrod Prediction of enzyme family classes J. Prot. Res. 2 2003 183 190
21. K.C. Chou, and W.J. Howe Prediction of the tertiary structure of the beta-secretase zymogen Biochem. Biophys. Res. Commun. 292 2002 702 708
22. K.C. Chou, D. Jones, and R.L. Heinrikson Prediction of the tertiary structure and substrate binding site of caspase-8 FEBS Lett. 419 1997 49 54
23. K.C. Chou, K.J. Kezdy, and F. Reusser Review: Steady-state inhibition kinetics of precessive nucleic acid polymerases and nucleases Anal. Biochem. 221 1994 217 230
24. K.C. Chou, K.D. Watenpaugh, and R.L. Heinrikson A model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator Biochem. Biophys. Res. Commun. 259 1999 420 428
25. K.C. Chou, D.Q. Wei, and W.Z. Zhong Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS Biochem. Biophys. Res. Comm. 308 2003 148 151 Erratum: ibid, vol. 310, 675
26. K.C. Chou, and C.T. Zhang Diagrammatization of codon usage in 339 HIV proteins and its biological implication AIDS Research and Human Retroviruses 8 1992 1967 1976
27. A. Dalby, J.G. Nourse, W.D. Hounsell, A.K.I. Gushurst, D.L. Grier, B.A. Leland, and J. Laufer J. Chem. Inf. Comput. Sci. 32 1992 244 255
28. J. Devereux The Wisconsin sequence analysis package Genetic Computer Group (GCG) 1994 Madison Wisconsin
29. P. Ertl J. Chem. Inf. Comput. Sci. 43 2003 374 380
30. M. Feher, and J.M. Schmidt J. Chem. Inf. Comput. Sci. 43 2003 218 227
31. M. Hann, B. Hudson, X. Lewell, R. Lifely, L. Miller, and N. Ramsden J. Chem. Inf. Comput. Sci. 39 1999 897 902
32. A.R. Leach, J. Bradshaw, D.V. Green, M.M. Hann, and J.J. Delany J. Chem. Inf. Comput. Sci. 39 1999 1161 1172
33. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249
34. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P. Feeney J. Adv. Drug Deliv. Rev. 46 2001 3 26
35. S.L. McGovern, E. Caselli, N. Grigorieff, and B.K. Shoichet J. Med. Chem. 45 2002 1712 1722
36. MOE, molecular operating environment, chemical computing group, Montreal, Que., Canada, 2003.
37. T.I. Oprea Property distribution of drug-related chemical databases J. Comput. Aided Mol. Des. 14 2000 251 264
38. T.I. Oprea, A.M. Davis, S.J. Teague, and P.D. Leeson J. Chem. Inf. Comput. Sci. 41 2001 1308 1315
39. G.M. Rishton Reactive compounds and in vitro false positives in HTS Drug Discov. Today 2 1997 382 384
40. G.M. Rishton Nonlead-likeness and lead-likeness in biochemical screening Drug Discov. Today. 8 2003 86 96
41. O.S. Roche, P. Zuegge, J. Guba, W. Kansy, M. Alanine, A. Bleicher, K. Danel, F. Gutknecht, E.M. Rogers-Evans, M. Neidhart, W. Stalder, H. Dillon, M. Sjogren, E. Fotouhi, N. Gillespie, P. Goodnow, R. Harris, W. Jones, P. Taniguchi, M. Tsujii, S. von der Saal, W. Zimmermann, and G. Schneider J. Med. Chem. 45 2002 137 142
42. D.E. Root, S.P. Flaherty, B.P. Kelley, and B.R. Stockwell Chem. Biol. 10 2003 881 892
43. J. Sadowski, and H. Kubinyi J. Med. Chem. 41 1998 3325 3329
44. S. Sirois, D.Q. Wei, Q. Du, and K.C. Chou Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points J. Chem. Inf. Comput. Sci. 44 2004 1111 1122
45. S.J. Teague, A.M. Davis, P.D. Leeson, and T.I. Oprea Angew Chem. Int. Ed. Engl. 38 1999 3743 3748
46. M.C. Wenlock, R.P. Austin, P. Barton, A.M. Davis, and P.D. Leeson J. Med. Chem. 46 2003 1250 1256
47. S.A. Wildman, and G.M. Crippen Prediction of physicochemical parameters by atomic contributions J. Chem. Inf. Comput. Sci. 39 1999 868 873
48. J. Xu, and J. Stevenson Drug-like index: a new approach to measure drug-like compounds and their diversity J. Chem. Inf. Comput. Sci. 40 2000 1177 1187
49. G.P. Zhou, and M.H. Deng An extension of Chou's graphical rules for deriving enzyme kinetic equations to system involving parallel reaction pathways Biochem. J. 222 1984 169 176